Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Trench Foot discovery paves way for new treatment

Trench Foot discovery paves way for new treatment

Clinical Neurology Research

A team including Professor David Bennett has uncovered the physical cause of trench foot more than 100 years after the painful and debilitating condition was first identified in the First World War.

Potential new route to treatment for Cerebellar Ataxia?

Potential new route to treatment for Cerebellar Ataxia?

Clinical Neurology Research

Researchers from the teams of Andrea Németh (NDCN) and Esther Becker (DPAG) have published an important paper reporting dominant mutations that cause a new type of cerebellar ataxia, Spinocerebellar Ataxia type 44.

James Parkinson 200th anniversary events

James Parkinson 200th anniversary events

Clinical Neurology Event

This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.

New consortium to investigate Alzheimer’s and Parkinson’s diseases

New consortium to investigate Alzheimer’s and Parkinson’s diseases

Research Clinical Neurology

New research project could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s diseases.

Cannabinoid biomedicine research programme launched

Cannabinoid biomedicine research programme launched

Research Clinical Neurology

Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.

New Oxford Neurodevelopment Consortium

New Oxford Neurodevelopment Consortium

Research Clinical Neurology

Professor Andrea Németh has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).

New drug trial for Parkinson's

New drug trial for Parkinson's

Research Clinical Neurology

Our researchers have been granted 600K euros from EU’s Horizon 2020 Framework Programme to join in a multi-centre initiative studying a new drug for Parkinson's disease

Brain activity predicts the force of your actions

Brain activity predicts the force of your actions

Research Clinical Neurology

A clear link between the activity in nerve clusters in the brain and the amount of force generated in a physical action has been demonstrated by our researchers, opening the way for the development of better devices to assist paralysed patients.

Study paves the way for new autoimmune disease treatments with fewer side effects

Study paves the way for new autoimmune disease treatments with fewer side effects

Research Clinical Neurology

New research from our Department has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease.

Medical Research Council awards £4.3m to boost UK research base in dementia

Medical Research Council awards £4.3m to boost UK research base in dementia

Award Clinical Neurology

Six universities including Oxford have been awarded a total of £4.3m by the Medical Research Council (MRC) to grow and develop the UK’s research base in dementia science.

New test for Parkinson’s disease moves a step closer

New test for Parkinson’s disease moves a step closer

Research Clinical Neurology

Scientists from the Oxford Parkinson’s Disease Centre (OPDC) and the Edinburgh Prion Unit have developed a new diagnostic test for Parkinson’s disease. The test measures the 'stickiness' of a particular protein in the cerebrospinal fluid.

Spinout develops smart glasses

Spinout develops smart glasses

Research Clinical Neurology Ophthalmology

A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

Researcher wins prize for engaging the public

Researcher wins prize for engaging the public

Award Clinical Neurology

The 12 winners of the inaugural University of Oxford's Vice-Chancellor’s Awards for Public Engagement with Research were announced on Friday 1 July by the Vice-Chancellor, Professor Louise Richardson, in a ceremony at Merton College.

Scientists pinpoint molecular signal that drives and enables spinal cord repair

Scientists pinpoint molecular signal that drives and enables spinal cord repair

Research Clinical Neurology

Dave Bennett and colleagues from King's College London have identified a molecular signal which drives and enables the spinal cord’s natural capacity for repair after injury. The findings could one day lead to new treatments which enhance this spontaneous repair mechanism..

Load More +